Clinical trial

A Study of a Novel Precision Medicine Approach For Obesity

NCT06814938

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2025-02-21

PhasePHASE4

Study timeline

Study start (actual)2025-02-21Date precision: day

Registry last updated2026-07-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Interventions

SemaglutideDRUG · verified · RxNorm: semaglutide

PlaceboDRUG

Sponsors & collaborators

Mayo Cliniclead sponsor

National Institutes of Health (NIH)collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Phenomix Sciencescollaborator

Mapped research locations

JacksonvilleFlorida, United States1 RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06814938 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.